Epirus, Ranbaxy launch Remicade biosimilar

Epirus Biopharmaceuticals Inc. (NASDAQ:EPRS) and partner Ranbaxy Laboratories Ltd. (NSE:RANBAXY; BSE:500359)

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE